Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule

Prostate cancer and the human papilloma virus: causative association, role of vaccines, and the impact of the COVID-19 pandemic

“…This may be of greater relevance than ever before, as the COVID-19 pandemic has posed a significant challenge to HPV vaccination campaigns. Unfortunately, short-term measures to mitigate the spread of COVID-19, such as school closures and limited clinic visits, have led to a fall in HPV vaccination rates [ 12 ]. In the United States, there was an 80% reduction in HPV vaccine orders by the end of March 2020, compared to the same time in the previous year [ 13 , 14 ] and a parallel marked reduction of HPV vaccine uptake in Europe [ 7 ].…”